Immune Checkpoint Blockade in Hepatocellular Carcinoma: 2017 Update. - Wikidata - awgldk - TriplyDB

Immune Checkpoint Blockade in Hepatocellular Carcinoma: 2017 Update.

Immune Checkpoint Blockade in Hepatocellular Carcinoma: 2017 Update.

http://www.wikidata.org/entity/Q42351579

about

Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions.Targeting the PD-1 pathway: a new hope for gastrointestinal cancers.Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer.Immunomodulation in hepatocellular cancer.Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy.Immune checkpoint therapy in liver cancer.Immune Gene Expression Profile in Hepatocellular Carcinoma and Surrounding Tissue Predicts Time to Tumor Recurrence Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)Proposal of Primary Endpoints for TACE Combination Trials with Systemic Therapy: Lessons Learned from 5 Negative Trials and the Positive TACTICS Trial Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma

P2860

Q38755178-AE21E5DE-BF82-48EB-9CE4-DF1ADDDD20B6 Q39038545-3265E697-D164-41CE-B9E2-DF2C40BEE7D3 Q42369857-D7FF9E8C-85E7-4C65-BC52-A9DDE1FB2397 Q52346985-EEF2C55E-E999-4E6A-AF87-4B755F3A4372 Q52722792-F36EB051-8639-48A2-8A32-602D3D4DF8E7 Q55008806-E115CE61-A0EE-4221-B709-7C2EEA0921D6 Q57494809-FC209922-DD3B-4C32-A2C1-57159C645664 Q57494813-FE771973-0F1B-46FB-8DC1-DE888DE59D6B Q57494815-ECA78B4E-DE38-41E8-8AE8-3C50613C583C Q58707841-41D247EE-4EE6-4C69-BF36-2E54FE6B4581

P2860

Immune Checkpoint Blockade in Hepatocellular Carcinoma: 2017 Update.

http://www.wikidata.org/entity/Q42351579

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Immune Checkpoint Blockade in Hepatocellular Carcinoma: 2017 Update.

@en

Immune Checkpoint Blockade in Hepatocellular Carcinoma: 2017 Update.

@nl

type

label

Immune Checkpoint Blockade in Hepatocellular Carcinoma: 2017 Update.

@en

Immune Checkpoint Blockade in Hepatocellular Carcinoma: 2017 Update.

@nl

prefLabel

Immune Checkpoint Blockade in Hepatocellular Carcinoma: 2017 Update.

@en

Immune Checkpoint Blockade in Hepatocellular Carcinoma: 2017 Update.

@nl

P1433

Q42351579-3F35E462-9577-4430-B8CD-0AFB65BEB60D

P1476

Q42351579-CCEB5A5A-48F3-4B46-974E-58356E2CC807

P2093

Q42351579-6E8A1833-9EA3-4F54-B4D4-F166307E3C22

P2860

Q42351579-091E3E5D-6098-4DE6-A5C6-BE2B91EB4D2B

Q42351579-0A960A13-8DBD-490A-801D-6907C031E1A3

Q42351579-0DB14C82-C5EE-4137-A573-DA7D074AED93

Q42351579-0F99827E-ABAB-46A6-B88C-9EF05A0E093C

Q42351579-12FFE7A2-9772-4F82-88C8-B64FA981C1A2

Q42351579-13E522DB-0A4C-41FA-A6C1-387A1ACF6FF7

Q42351579-17297D3F-A455-4693-84C6-9B365F7F38B2

Q42351579-1BC2A214-1E92-4027-8862-7237E7C77A30

Q42351579-1DB3FC51-AF1B-406D-9248-9598A1FD7C81

Q42351579-1E46C64C-C82B-44C2-8BFA-2DC21F90E9FC

P304

Q42351579-313306A9-5328-41FE-86F7-73BB2C46A4BD

P31

Q42351579-00343ea7-4509-4e08-9c05-b6cf84c9ed6c

Q42351579-DCE979C9-93CF-48C8-83EB-4D4069C50583

P356

Q42351579-E9C44779-D4F8-4B43-A539-A96746282F86

P433

Q42351579-2719FF5B-BCFB-4AB5-8562-B6EBC62A2DE3

P478

Q42351579-EB19E488-43C3-4775-A9C8-5980D7420489

P577

Q42351579-2E323451-D564-4CC4-AF96-8037C91A3B39

P698

Q42351579-BEE14F47-9794-4845-B405-676165223B32

P932

Q42351579-BF731B9B-AD9A-4C5D-8E98-DB2D4A2E2953

P356

P1433

P1476

Immune Checkpoint Blockade in Hepatocellular Carcinoma: 2017 Update.

@en

P2093

M Kudo

http://www.w3.org/2001/XMLSchema#string

P2860

Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

Image-Guided Ablation of Malignant Liver Tumors: Recommendations for Clinical Validation of Novel Thermal and Non-Thermal Technologies - A Western Perspective

Recent Advances in Tumor Ablation for Hepatocellular Carcinoma

Nivolumab plus ipilimumab in advanced melanoma.

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma

P304

1-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000449342

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27995082

http://www.w3.org/2001/XMLSchema#string

P932

5159737

http://www.w3.org/2001/XMLSchema#string